A mobile application used to assess sports-related head and brain injuries is now being tested for detecting and monitoring neurological disorders.
BrainEye's mobile test is now being studied in clinical trials at The Alfred Hospital in Melbourne. It digitises the traditional eye movement test, which is done in 60 seconds through a mobile device, and then collects and measures over 20 ocular...
Japanese pharmaceutical company Eisai, together with Oita University in Japan, has built what could be the world's first AI model that uses data from wearable devices to predict Alzheimer's disease, the most common form of dementia.
Their research team embarked on a study to create a cost-effective, practical tool to pre-screen people suspected of developing the disease. Their findings were...
The healthcare unit of South Korean diversified conglomerate Lotte has teamed up with iMediSync to co-develop new AI-driven healthcare services.
Based on a press release, the two companies signed a memorandum of understanding to cooperate on a medium-to-long-term joint business venture that leverages AI technology for wellness and senior care. They also intend to work together on some marketing...
Researchers from the Commonwealth Scientific and Industrial Research Organisation, in partnership with the Queensland University of Technology, have developed what could be the world's first AI-based benchmark for measuring brain atrophy.
WHAT IT'S ABOUT
They used AI to develop a set of artificial MRI brain images with predefined signs of neurodegeneration in the cortex region, an area of the...
Breathe Well-being scores $6M in pre-Series B funding
Diabetes care startup Breathe Well-being from India has raised $6 million (Rs 500 million) in a pre-Series B round led by 3One4 Capital, Accel and General Catalyst.
Launched in 2020, the company focuses on behavioural and lifestyle changes to reduce and reverse the risk of Type 2 diabetes. It offers a clinically-proven digital programme that...
Direct-to-patient healthcare company Ro announced an agreement with the National Institute on Aging (NIA) to develop the Registry for Equal Access to Clinical Trials in Alzheimer's Disease (REACT-AD).
Ro will employ its telehealth platform to screen and recruit patients at elevated risk for developing Alzheimer's disease (AD) or other related dementia to join REACT-AD for potential participation...
Healthtech startup Lottie raises £2.5M for social care platform
British healthtech startup Lottie has announced £2.5 million funding from Kindred Capital VC bringing the company's valuation to £28 million.
Lottie’s website collects data and insights to help users find the most appropriate care homes in the UK at a fair price.
The new funding will go towards improving the firm’s digital platform...
BrainCheck, the company behind a platform that helps assess cognitive impairment, has raised $10 million in Series B funding.
The round was led by Next Coast Ventures and S3 Ventures, with participation from Nueterra Capital, Tensility Ventures and True Wealth Ventures. BrainCheck also secured strategic investment from UPMC Enterprises and SelectQuote.
BrainCheck said the latest round of funding...
A Boston-based startup is looking to help treat neurodegenerative disease with a smartphone-based digital therapeutic called Neuroglee.
This morning the startup got a boost when it closed a $10 million Series A round led by Openspace Ventures with participation from EDBI, Eisai Co and individual investors.
“Various techniques have been demonstrated to slow or improve cognitive impairment in...
Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences.
The startup and its CEO Ed Cox became one of the developing space's many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimer's symptoms treatment, with Cox chairing a handful of industry...
